Seoul, South Korea

Young Kweon Choi

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2008-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Sure, here is the article for inventor Young Kweon Choi:

Title: Innovator Spotlight - Young Kweon Choi: Revolutionizing Oral Anticancer Drug Delivery

Introduction:

Young Kweon Choi, a distinguished inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals with a focus on enhancing the oral delivery of anticancer drugs. With an impressive portfolio of 5 patents to his name, Choi's innovative approach has the potential to transform the way anticancer medications are administered.

Latest Patents:

Choi's groundbreaking patents include:

1. Oral pharmaceutical composition containing pemetrexed and production method thereof: This patent introduces an oral pharmaceutical composition that improves the oral bioavailability of pemetrexed, a water-soluble anticancer drug. By incorporating an ion-binding complex of pemetrexed and a bile acid derivative, the formulation can be administered orally, offering a more convenient alternative to injection formulations.

2. Oral drug delivery composition containing oxaliplatin and method for preparing same: Another notable patent by Choi focuses on enhancing the oral bioavailability of oxaliplatin, a water-soluble anticancer agent. By developing an oral delivery composition with an ionic complex of oxaliplatin and a bile acid derivative, this innovation aims to improve patient compliance and reduce medical costs associated with injection-based treatments.

Career Highlights:

Young Kweon Choi has garnered experience working with reputable companies in the pharmaceutical industry, including Icure Pharmaceutical Corp. and Icure BNP Co., Ltd. His expertise in drug delivery systems and formulation development has paved the way for novel advancements in cancer treatment, emphasizing the importance of patient-centric solutions.

Collaborations:

Throughout his career, Choi has collaborated with industry experts such as Jin Woo Park and Young Ro Byun. These partnerships have fostered a collaborative environment for innovation, leading to the successful development of new drug delivery technologies that benefit patients worldwide.

Conclusion:

Inventor Young Kweon Choi's dedication to revolutionizing oral anticancer drug delivery underscores his commitment to improving patient outcomes and healthcare accessibility. Through his pioneering patents and collaborations within the pharmaceutical sector, Choi continues to drive innovation in the field of oncology, ultimately advancing the future of cancer treatment.

If you need further information or assistance, feel free to contact us at idiyas.com.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…